Xian Deng
Stock Analyst at UBS
(4.46)
# 1,143
Out of 4,651 analysts
172
Total ratings
62.1%
Success rate
17%
Average return
Main Sectors:
Stocks Rated by Xian Deng
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0MGB Genmab A/S | Maintained: Buy | kr 2,600 → kr 2,700 | kr 2,027 | +33.20% | 37 | Aug 7, 2026 | |
| ARGX argenx SE | Maintained: Hold | $850 → $960 | $851.29 | +12.77% | 34 | Aug 6, 2026 | |
| LON: 0QW0 argenx SE | Maintained: Hold | n/a | $730.50 | - | 13 | Aug 6, 2026 | |
| LON: 0NZT UCB SA | Maintained: Buy | €330.00 → €310.00 | €215.55 | +43.82% | 24 | Aug 4, 2026 | |
| EPA: IPN Ipsen S.A. | Maintained: Hold | €170.00 | €156.00 | +8.97% | 24 | Aug 3, 2026 | |
| ZLDPF Zealand Pharma A/S | Maintained: Buy | $117 → $113 | $52.68 | +114.16% | 3 | May 8, 2026 | |
| AMS: LKFT Lakefront Biotherapeutics NV | Maintained: Hold | €30.00 | €23.90 | +25.52% | 4 | Apr 1, 2026 | |
| SWX: BIOV BioVersys AG | Initiated Coverage: Buy | CHF 48.00 | CHF 26.50 | +81.13% | 2 | Dec 11, 2025 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 720.00 → CHF 605.00 | CHF 562.60 | n/a | 12 | Feb 6, 2023 | |
| FRA: MDG1 Medigene AG | Maintained: Buy | €8.00 | €0.02 | n/a | 6 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | kr 480.00 → kr 450.00 | kr 516.50 | n/a | 7 | May 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 255.00 | kr 202.44 | n/a | 2 | Feb 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €31.00 | €20.02 | n/a | 4 | Nov 1, 2019 |
Genmab A/S
Aug 7, 2026
Maintained: Buy
Price Target: kr 2,600 → kr 2,700
Current: kr 2,027
Upside: +33.20%
argenx SE
Aug 6, 2026
Maintained: Hold
Price Target: $850 → $960
Current: $851.29
Upside: +12.77%
argenx SE
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $730.50
Upside: -
UCB SA
Aug 4, 2026
Maintained: Buy
Price Target: €330.00 → €310.00
Current: €215.55
Upside: +43.82%
Ipsen S.A.
Aug 3, 2026
Maintained: Hold
Price Target: €170.00
Current: €156.00
Upside: +8.97%
Zealand Pharma A/S
May 8, 2026
Maintained: Buy
Price Target: $117 → $113
Current: $52.68
Upside: +114.16%
Lakefront Biotherapeutics NV
Apr 1, 2026
Maintained: Hold
Price Target: €30.00
Current: €23.90
Upside: +25.52%
BioVersys AG
Dec 11, 2025
Initiated Coverage: Buy
Price Target: CHF 48.00
Current: CHF 26.50
Upside: +81.13%
Lonza Group AG
Feb 6, 2023
Maintained: Buy
Price Target: CHF 720.00 → CHF 605.00
Current: CHF 562.60
Upside: n/a
Medigene AG
Aug 4, 2022
Maintained: Buy
Price Target: €8.00
Current: €0.02
Upside: n/a
May 26, 2020
Downgraded: Hold
Price Target: kr 480.00 → kr 450.00
Current: kr 516.50
Upside: n/a
Feb 17, 2020
Maintained: Buy
Price Target: kr 255.00
Current: kr 202.44
Upside: n/a
Nov 1, 2019
Maintained: Buy
Price Target: €31.00
Current: €20.02
Upside: n/a